check out VRUS

Discussion in 'Stocks' started by cashmoney69, Jan 16, 2008.

  1. nice pop in the last few days.

    "Pharmasset (VRUS - Cramer's Take - Stockpickr): This company develops antiviral drugs to treat hepatitis C, hepatitis B and HIV. The company's stock rocketed recently on positive data from a phase II study of its hepatitis C drug R7128 combined with interferon and ribavirin (the current standard of care for hepatitis C).

    R7128 is being developed in a partnership with Roche, and there has been some speculation that the Swiss drug maker could buy Pharmasset outright. " -